Database→Epithalon

Tier 3–4Anti-agingTelomereNeuroendocrinePREMIUM

Epithalon

Epitalon / Epithalone (AEDG tetrapeptide · Ala-Glu-Asp-Gly)

Approved in Russia for 30+ years. Not FDA- or EMA-approved. FDA listed among substances with potential safety risks for compounding (December 2023). No Western RCTs exist.

For research and educational purposes only · Not medical advice · Consult a qualified physician before any human use

Profile Overview

Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the bovine pineal gland. Its primary scientific focus is telomere biology: it activates telomerase and may induce ALT pathway activity in cell culture. All clinical data originates from a single Russian research group with no Western independent replication until the 2025 Biogerontology study. The entire evidence base must be interpreted with this structural limitation in mind.

🔒

Full Profile: Premium Members Only

The complete Epithalon profile includes all use cases with full evidence reviews, mechanism of action deep dive, safety analysis, evidence table, dosing guidance, and stack compatibility data.

For research and educational purposes only · Not medical advice · Consult a qualified physician before any human use